These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

273 related articles for article (PubMed ID: 36389774)

  • 21. Systematic Review with Meta-Analysis: Fecal Microbiota Transplantation for Severe or Fulminant Clostridioides difficile.
    Tixier EN; Verheyen E; Luo Y; Grinspan LT; Du CH; Ungaro RC; Walsh S; Grinspan AM
    Dig Dis Sci; 2022 Mar; 67(3):978-988. PubMed ID: 33748913
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Potential Role of the Host-Derived Cell-Wall Binding Domain of Endolysin CD16/50L as a Molecular Anchor in Preservation of Uninfected Clostridioides difficile for New Rounds of Phage Infection.
    Phothichaisri W; Chankhamhaengdecha S; Janvilisri T; Nuadthaisong J; Phetruen T; Fagan RP; Chanarat S
    Microbiol Spectr; 2022 Apr; 10(2):e0236121. PubMed ID: 35377223
    [TBL] [Abstract][Full Text] [Related]  

  • 23. The evaluation of fecal microbiota transplantation vs vancomycin in a Clostridioides difficile infection model.
    Xu Q; Zhang S; Quan J; Wu Z; Gu S; Chen Y; Zheng B; Lv L; Li L
    Appl Microbiol Biotechnol; 2022 Oct; 106(19-20):6689-6700. PubMed ID: 36085529
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Fecal microbiota transplantation for treatment of patients with recurrent
    Voth E; Khanna S
    Expert Rev Anti Infect Ther; 2020 Jul; 18(7):669-676. PubMed ID: 32266848
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Complete Microbiota Engraftment Is Not Essential for Recovery from Recurrent Clostridium difficile Infection following Fecal Microbiota Transplantation.
    Staley C; Kelly CR; Brandt LJ; Khoruts A; Sadowsky MJ
    mBio; 2016 Dec; 7(6):. PubMed ID: 27999162
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Microbial bile salt hydrolases mediate the efficacy of faecal microbiota transplant in the treatment of recurrent
    Mullish BH; McDonald JAK; Pechlivanis A; Allegretti JR; Kao D; Barker GF; Kapila D; Petrof EO; Joyce SA; Gahan CGM; Glegola-Madejska I; Williams HRT; Holmes E; Clarke TB; Thursz MR; Marchesi JR
    Gut; 2019 Oct; 68(10):1791-1800. PubMed ID: 30816855
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Diluted Fecal Community Transplant Restores Clostridioides difficile Colonization Resistance to Antibiotic-Perturbed Murine Communities.
    Lesniak NA; Tomkovich S; Henry A; Taylor A; Colovas J; Bishop L; McBride K; Schloss PD
    mBio; 2022 Aug; 13(4):e0136422. PubMed ID: 35913161
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Danish national guideline for the treatment of
    Baunwall SMD; Dahlerup JF; Engberg JH; Erikstrup C; Helms M; Juel MA; Kjeldsen J; Nielsen HL; Nilsson AC; Rode AA; Vinter-Jensen L; Hvas CL
    Scand J Gastroenterol; 2021 Sep; 56(9):1056-1077. PubMed ID: 34261379
    [No Abstract]   [Full Text] [Related]  

  • 29. FMT: What's Next? A Narrative Review of Fecal Microbiota Transplantation in Clostridioides difficile Infection and Inflammatory Bowel Disease.
    Patwa SA; Ward C; Kelly CR
    R I Med J (2013); 2022 Nov; 105(9):20-24. PubMed ID: 36300959
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Factors Related to Outcomes of Fecal Microbiota Transplantation in Patients with
    Yoon H; Shim HI; Seol M; Shin CM; Park YS; Kim N; Lee DH
    Gut Liver; 2021 Jan; 15(1):61-69. PubMed ID: 32839363
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Cost-effectiveness analysis of sequential fecal microbiota transplantation for fulminant Clostridioides difficile infection.
    Gupta S; Zhu J; McCarty TR; Pruce J; Kassam Z; Kelly C; Fischer M; Allegretti JR
    J Gastroenterol Hepatol; 2021 Sep; 36(9):2432-2440. PubMed ID: 33682170
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Successful treatment of fulminant Clostridioides difficile infection with emergent fecal microbiota transplantation in a patient with acute myeloid leukemia and prolonged, severe neutropenia.
    Lee MSL; Ramakrishna B; Moss AC; Gold HS; Branch-Elliman W
    Transpl Infect Dis; 2020 Feb; 22(1):e13216. PubMed ID: 31769569
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Fecal microbiota transplantation as therapy for recurrent Clostridioides difficile infection is associated with amelioration of delirium and accompanied by changes in fecal microbiota and the metabolome.
    Gotoh K; Sakaguchi Y; Kato H; Osaki H; Jodai Y; Wakuda M; Také A; Hayashi S; Morita E; Sugie T; Ito Y; Ohmiya N
    Anaerobe; 2022 Feb; 73():102502. PubMed ID: 34896553
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Durability of Response to Fecal Microbiota Transplantation After Exposure to Risk Factors for Recurrence in Patients With Clostridioides difficile Infection.
    Saha S; Mara K; Pardi DS; Khanna S
    Clin Infect Dis; 2021 Oct; 73(7):e1706-e1712. PubMed ID: 32976567
    [TBL] [Abstract][Full Text] [Related]  

  • 35. [Faecal microbiota transplantation for Clostridioides difficile infection].
    Waldbaum C; López F; Antelo P; Sorda J
    Medicina (B Aires); 2020; 80(6):633-639. PubMed ID: 33254107
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Microbiota or placebo after antimicrobial therapy for recurrent
    Drekonja DM; Shaukat A; Zhang JH; Reinink AR; Nugent S; Dominitz JA; Davis-Karim A; Gerding DN; Kyriakides TC
    Clin Trials; 2021 Oct; 18(5):622-629. PubMed ID: 34154439
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Fecal microbiota-based treatment for recurrent Clostridioides difficile infection.
    Walter J; Shanahan F
    Cell; 2023 Mar; 186(6):1087. PubMed ID: 36931236
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Frontiers in antibiotic alternatives for
    Phanchana M; Harnvoravongchai P; Wongkuna S; Phetruen T; Phothichaisri W; Panturat S; Pipatthana M; Charoensutthivarakul S; Chankhamhaengdecha S; Janvilisri T
    World J Gastroenterol; 2021 Nov; 27(42):7210-7232. PubMed ID: 34876784
    [No Abstract]   [Full Text] [Related]  

  • 39. Fecal Microbiota Transplantation Is Safe and Effective in Patients With Clostridioides difficile Infection and Cirrhosis.
    Cheng YW; Alhaffar D; Saha S; Khanna S; Bohm M; Phelps E; Ghabril M; Orman E; Sashidhar S; Rogers N; Xu H; Khoruts A; Vaughn B; Kao D; Wong K; Cammarota G; Ianiro G; Dhere T; Kraft CS; Mehta N; Woodworth MH; Allegretti JR; Nativ L; Marcus J; El-Nachef N; Fischer M
    Clin Gastroenterol Hepatol; 2021 Aug; 19(8):1627-1634. PubMed ID: 32645451
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Clinical practice guidelines for Clostridioides (Clostridium) difficile infection and fecal microbiota transplant protocol - recommendations of the Polish Society od Epidemiology and Infectious Diseases.
    Piekarska A; Panasiuk A; Stępień PM
    Przegl Epidemiol; 2020; 74(1):69-87. PubMed ID: 32500988
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 14.